Clinical Trials Directory

Trials / Unknown

UnknownNCT00889902

Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Wuhan University · Academic / Other
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to: 1. make p16INK4A as a cervical cancer screening of tumor markers, cytology improve existing diagnostic sensitivity, specificity, repeatability and validity, so as to effectively prompted the early discovery and diagnosis of cervical cancer. 2. reduce screening costs, screening and benefits into quantitative evaluation, for our country to develop cervical cancer prevention and control strategy to provide a reliable theoretical basis.

Detailed description

1. To carry out large-scale prospective randomized controlled clinical study to evaluate the "cytological molecular markers Detect + P16INK4A" methods of screening accuracy and reliability, as well as the screening method of the biological effects. 2. Markov set up mathematical model of screening tests to quantify the inputs and the evaluation proceeds. With a view to optimize and perfect a simple, convenient, practical and efficient program of cervical cancer screening.

Conditions

Timeline

Start date
2009-04-01
Primary completion
2010-06-01
Completion
2011-07-01
First posted
2009-04-29
Last updated
2009-04-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00889902. Inclusion in this directory is not an endorsement.